Best practices to measure cytokines in whole blood with AlphaLISA

Unlock the potential of whole blood analysis for a more accurate and physiologically relevant assessment of biomarkers. Whole blood encompasses all the natural components of blood, offering an environment that enhances cell viability and simplifies the analytical process by reducing the need for extensive sample preparation. This comprehensive matrix allows for a better understanding of cytokine profiles and other critical biomarkers directly in their native state.

For researchers utilizing whole blood samples or seeking to integrate this method into their work, Revvity's AlphaLISA™ technology offers a highly sensitive, homogeneous assay for efficient and precise biomarker detection in whole blood. Download this application note to explore how AlphaLISA can streamline your biomarker analysis, delivering reliable results while overcoming the typical challenges associated with whole blood samples.

For research use only. Not for use in diagnostic procedures.